arritmia cardíaca com uso de oxamniquine oral no tratamento de esquistossomose mansônica cardiac arrhythmia with oral oxamniquine in the treatment of schistosomiasis mansoni
Clicks: 188
ID: 181599
1993
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
188 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #100 of 173 articles by views in 2017 12th international conference for internet technology and secured transactions, icitst 2017
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 173 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Os autores relatam caso clínico de paciente com esquistossomose mansônica, tratado com oxamniquine oral em dose única de 15 mg/kg, que apresenta como efeito colateral um bloqueio átrio-ventricular incompleto tipo Mobitz I, com parada sinusal e escape ventricular. Concluem que, apesar de a oxamniquine ser eficaz e segura, pode ser determinante de cardiotoxicidade
The authors report a case of a patient with schistosomiasis (S.mansoni) treated with one single dose (15 mg/kg/BWT) of oral oxamniquine who presented Mobitz type I second-degree AV block and sinus arrest with ventricular escape as a side-effect. They conclude that in spite of the safety and good activity of oxamniquine it may be a determinant of cardiotoxicity
The authors report a case of a patient with schistosomiasis (S.mansoni) treated with one single dose (15 mg/kg/BWT) of oral oxamniquine who presented Mobitz type I second-degree AV block and sinus arrest with ventricular escape as a side-effect. They conclude that in spite of the safety and good activity of oxamniquine it may be a determinant of cardiotoxicity
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (114 words).
Try re-searching for a better abstract.
| Reference Key |
guitti1993revistaarritmia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;José Carlos dos Santos Guitti;Lúcio Navarro Gordan;José Luis da Silveira Baldy |
| Journal | 2017 12th international conference for internet technology and secured transactions, icitst 2017 |
| Year | 1993 |
| DOI |
10.1590/S0036-46651993000600018
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.